Ken Tarkoff

Mar 15, 2017

Syapse has appointed Ken Tarkoff as its CEO. Tarkoff was chief operating officer for RelayHealth and served as senior vice president and general manager of the firm after it was acquired by McKesson. Before his time at RelayHealth, Tarkoff served as director of supplier services at Xign Corporation. He has also served as vice president of product management at Questium and vice president of regional operations at Vivra Specialty Partners.

More Like This

Sep 20, 2017

Micah Litow

Micah Litow has joined cancer screening test firm Preora Diagnostics as its chief marketing and business development officer. He previously was at IA Collaborative where he led the healthcare practice. Before that, he was director of innovation at Leica Biosystems.

Sep 20, 2017

Patrick Young

True Health named Patrick Young to its board of directors. Young is president of Population Health for Hackensack Meridian Health. True Health provides biomarker testing cardiovascular diseases, diabetes, autoimmune disorders, metabolic conditions, and other ailments. It began offering its hereditary cancer test called genTrue earlier this year. 

Sep 19, 2017

Michael Korn

Michael Korn has been appointed the chief medical officer of Caris Life Sciences, where he will guide the firm's research efforts and clinical strategies for the Adapt Biotargeting System and Caris Molecular Intelligence tumor profiling. Korn is a professor of medicine in the division of hematology/concology at the University of California, San Francisco, and he replaces John Marshal, who was CMO for Caris on a part-time basis. Marshall will continue as chairman of the Precision Oncology Alliance, which is powered by Caris.

Sep 15, 2017

Philipp Manser, Karl Erik Clausen

Unilabs CFO Philipp Manser has resigned from the firm for personal reasons, the company said. Its previous CFO Karl Erik Clausen, who had retired, is rejoining Unilabs as interim CFO while the company searches for a permanent successor.

Sep 13, 2017

Felice Schnoll-Sussman

Felice Schnoll-Sussman has been elected a director at Interpace Diagnostics, where she will serve on the firm's audit committee. She will be a Class II director and her term expires in 2018. Schnoll-Sussman is an associate professor of clinical medicine at Weill Cornell Medical College, where she is the director of the Jay Monahan Center for Gastrointestinal Health. She also is associate attending physician in gastroenterology at New York Presbyterian Hospital. 

Sep 12, 2017

James Wisecarver

James Wisecarver has been installed as the 2017-2018 president of the American Society for Clinical Pathology. He is currently vice chair for clinical affairs and medical director of the University of Nebraska Medi al Center Clinical Laboratories. He also is the director of the Human DNA Identification Laboratory at UNMC. 

Sep 12, 2017

Gerald Krueger

DermTech has appointed Gerald Krueger to its scientific advisory board. Krueger is a professor of dermatology and Edna Benning Presidential Endowed Chair at the University of Utah. He received his medical degree from Loma Linda University and completed his residency in dermatology at the University of Colorado. Krueger is also the recipient of the Taub International Award for Psoriasis Research and a National Psoriasis Foundation Lifetime Achievement Award. DermTech noted that Krueger will help guide the company's efforts to develop non-invasive gene expression tests for inflammatory skin conditions.

Sep 08, 2017

Jamie Platt

Jamie Platt has joined Inivata as chief operations officer. She will be based at Inivata's Research Triangle Park, North Carolina facility. Platt joins Inivata from Quest Diagnostics, where she helped lead that company's early advanced sequencing strategy and product portfolio. She holds a PhD in molecular and cellular biology from Oregon State University and completed her postdoc in population genetics at the University of California, Berkeley.

Sep 06, 2017

Michael Brawer

MDxHealth has appointed Michael Brawer as chief medical officer. Brawer is a urologist and former professor of urology and pathology. He most recently served as vice president of medical affairs for urology at Myriad Genetics, where he led all clinical aspects of development, education, and commercialization of the firm's prognostic prostate cancer assay. Previously, Brawer held senior leadership positions at GTx, Tokai Pharmaceuticals, and Threshold Pharmaceuticals. HE was also a practicing urologist and the director of the Northwest Prostate Institute for almost a decade, and held teaching positions in pathology and urology at the University of Washington and University of Arizona.

Sep 06, 2017

Sandra Cole

BioReference Laboratories has appointed Sandra Cole vice president and chief compliance officer. Previously, she served as the company’s compliance and privacy officer. In her new role, Cole will oversee a department responsible for restructuring the company’s compliance and privacy programs. In addition, she will oversee core compliance processes, including risk assessments, metrics, analytics, and corporate policy.

 

Sep 05, 2017

Christopher Rieder

Christopher Rieder has joined Aurora Diagnostics as its chief information officer. Rieder was most recently CIO of Brookdale University Hospital and Medical Center and has more than 20 years of experience in information technology and a background in operations, management, and organizational leadership.

Sep 05, 2017

Michael Vicari

OncoCyte has appointed Michael Vicari to a newly created position of vice president of sales, in which he will report directly to president and CEO William Annett. In his new role, Vicari will be responsible for the development and successful implementation of domestic and international sales strategies for OncoCyte, with an initial focus on the expected fourth quarter US launch of the firm's liquid biopsy lung cancer test DetermaVu.

Vicari comes with 35 years of successful sales and marketing leadership within the healthcare industry, including the launch of several important diagnostic products, OncoCyte said. He previously worked with Eurofins Scientific as VP of sales & marketing for the company's clinical diagnostics business. Prior to Eurofins, he was VP of sales for Sequenom, for Monogram Biosciences, and served in senior commercial leadership roles at Genentech, Corixa Oncology, and MedImmune.

Aug 31, 2017

Stefan Linn

Oxford Immunotec appointed Stefan Linn its chief operating officer. He was most recently senior vice president, strategy and commercial operations for IMS Health Holdings, where he was responsible for advancing that firm's global growth agenda. Prior to that, he was at TPG Capital , where he helped its healthcare and consumer portfolio firms drive operating improvements. 

Aug 24, 2017

Brian Caveney

Brian Caveney will join Laboratory Corporation of America as enterprise-wide chief medical officer on Sept. 25. He will report to LabCorp Chairman and CEO David King. In the newly created role, Caveney will oversee LabCorp’s medical and scientific strategy, and serve as the company’s primary external medical representative, defining global standards for medical and scientific activities across LabCorp’s diagnostic and drug development businesses. Caveney is currently chief medical officer of Blue Cross and Blue Shield of North Carolina. 

Aug 23, 2017

Herman Rosenman

Herman Rosenman has been appointed to the board of directors of DermTech. Rosenman was most recently CFO at Natera, from January 2014 to January 2017. Prior to that he was senior vice president of finance and CFO at Gen-Probe (now part of Hologic). He has also served as president and CEO of RadNet Management and CFO of Rexene.